01—Abstract
Summary
Summary of the 8-K filed October 31, 2025. Cited figures are marked; the original filing is the authoritative source.
CoreWeave (CRWV) disclosed in an 8-K dated October 30, 2025 that its proposed all-stock acquisition of Core Scientific, Inc. has been terminated.
The merger agreement, signed July 7, 2025, would have made Core Scientific a wholly owned subsidiary of CoreWeave. At a Core Scientific special stockholder meeting on October 30, 2025, the requisite stockholders did not approve the merger proposal, and Core Scientific terminated the agreement effective immediately under its terms. The filing reports the outcome, not a financial impact, and no termination fee or other payment obligation is disclosed in the filing text provided.
Management framed the outcome as a respect for Core Scientific shareholders' views. CEO Michael Intrator said CoreWeave's strategy is unchanged, that the company will keep executing its roadmap, and that it will pursue opportunistic and strategic M&A. The companies also said they will continue their longstanding commercial partnership, in which CoreWeave is a major customer of Core Scientific's data center capacity, and collaborate on shared opportunities.
For investors, the key takeaways are that a large, announced growth transaction is off the table, that the strategic relationship continues, and that the filing itself leaves open questions about any termination costs, the effect on CoreWeave's capacity pipeline, and how management will redeploy its M&A ambitions. Investors should review the Core Scientific 8-K for final vote tallies and any fee-related disclosures in the merger agreement.
02—Key points
Key Highlights
- Core Scientific stockholders did not approve the merger proposal at the October 30, 2025 special meeting, so the all-stock acquisition by CoreWeave was terminated effective immediately.
- The merger agreement, signed July 7, 2025, would have made Core Scientific a wholly owned CoreWeave subsidiary through a merger sub structure.
- The filing discloses no termination fee or other financial payment in the text provided; investors should check the merger agreement for any such provisions.
- CoreWeave's CEO stated the company's strategy is unchanged and that it will pursue opportunistic and strategic M&A going forward.
- The commercial partnership between CoreWeave and Core Scientific is expected to continue, with both companies pursuing collaboration on shared opportunities.
- Final voting results will be reported by Core Scientific in its own Form 8-K, so the precise vote count is not in this CoreWeave filing.
- The press release is furnished under Item 7.01 and is not deemed filed for Exchange Act Section 18 purposes.
03—Questions
Frequently Asked Questions
Why was the Core Scientific acquisition terminated?
Core Scientific stockholders did not approve the proposal to adopt the merger agreement at the October 30, 2025 special meeting. Because the required approval was not obtained, Core Scientific terminated the agreement under its terms, effective immediately.
Does CoreWeave owe a termination fee or pay any penalty?
The filing text provided does not state any termination fee or payment obligation. Investors should consult the July 7, 2025 Merger Agreement, which was previously disclosed, for any fee or expense reimbursement provisions.
Will CoreWeave's relationship with Core Scientific end?
No. Both companies said they will continue their longstanding commercial partnership and collaborate on shared opportunities that leverage their complementary strengths, though the merger itself is no longer pending.
What does this mean for CoreWeave's growth strategy?
CEO Michael Intrator said the strategy remains unchanged and that CoreWeave will continue executing its roadmap, including opportunistic and strategic M&A. The filing does not provide new financial guidance or describe a replacement transaction.
Where can investors find the final vote results?
The final voting results will be reported in a Form 8-K filed by Core Scientific with the SEC. The preliminary results cited in CoreWeave's press release were not broken out numerically in this filing.
04—Continue